Get to know Dr. Michelle Weiner, Medical Advisor to Endocanna Health.
At Endocanna Health, cannabis is personal. It’s our life’s work. Collectively, our professional staff has decades of experience studying and researching plant medicine, biotech innovations, and the endocannabinoid system.
Below, get to know Dr. Michelle Weiner, who is double board-certified in Interventional Pain Medicine and Physical Medicine and Rehabilitation. She completed her residency and fellowship training at the University of Miami. She is the Chair on the Florida’s Medical Cannabis Advisory Committee.
Dr. Weiner’s unique approach of personalized and preventative medicine focuses on empowering her patients to cultivate health using lifestyle and plant medicine. Her research focuses on using cannabis as a substitute for opioids in chronic pain patients. She is conducting a pharmacokinetic study at the University of Miami investigating how to optimize the bioavailability of cannabinoids using water soluble nanoemulsions.
She is faculty and a preceptor at Nova Southeastern University in which she educates the medical students through shadowing opportunities in her office. Dr. Weiner is the Vice President of Mr. Psychedelic Law, a non-for-profit with the mission of responsible legal reform of psilocybin mushrooms in Florida. She uses cannabis and ketamine assisted psychotherapy as a catalyst to identify the root cause of one’s suffering optimizing their quality of life.
Endocanna Health is a biotechnology company committed to helping consumers find the right cannabinoid products to enhance their health and wellness. Using our breakthrough DNA test, Endo·dna, we empower you to take control of your health with access to over 55 different health reports that include suggestions for the best CBD and cannabis products that match your unique genetic code. Visit us here to find out more!
